The defense against a mosquito-borne viral disease that has spread to over 125 countries and is one of the World Health Organization's top threats to global health expanded today in Brazil.
An innovative Dengue vaccine that does not require pre-vaccination testing was approved by the National Health Surveillance Agency (ANVISA) to prevent dengue in Brazil caused by any of the four virus serotypes.
Read More